S.D. NY Judge Paul Gardephe has dismissed antitrust claims alleging that Bayer had used patents on the drugs Yasmin and Yaz anticompetitively. The court dismissed on the ground that the plaintiff’s alleged relevant markets based on the active ingredients in the drugs were irrationally narrow.